Skip to main content
Back to Deerfield

Deerfield's Life Science Portfolio

Browse 12 Life Science companies funded by Deerfield. See funding amounts, founder contacts, and investment details.

Life Science Companies
12
Total Funding in Life Science
$1.1B

Life Science Portfolio Companies (12)

Export
BiotechnologyLife ScienceTherapeutics

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

San Francisco, United States
July 2022
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceuticalPrecision MedicineTherapeutics

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

San Francisco, United States
June 2024
$20.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncology

Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases

New York, United States
May 2022
$400K
Pre-Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.

Cambridge, United States
May 2022
$50.0M
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceOncologyTherapeutics

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Cambridge, United States
February 2026
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Life SciencePharmaceuticalTherapeutics

Perceive Pharma operates as a pharmaceutical company.

San Francisco, United States
February 2025
$15.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Cambridge, United States
January 2026
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

South San Francisco, United States
January 2023
$78.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareLife Science

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Cambridge, United States
January 2024
$100.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife Science

Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.

New York, United States
December 2025
$70.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.

Cambridge, United States
November 2025
$500.0M
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife Science

Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.

New York, United States
October 2022
Series E

Founder Contacts

41,000+ verified contacts

Explore Deerfield's Full Portfolio

View all companies funded by Deerfield across every industry and funding stage.

View Full Deerfield Portfolio
Deerfield Life Science Portfolio - 12 Companies | VCBacked